Introduction to Translational Medicine

1 Why ME/CFS Research Benefits Other Conditions

ME/CFS research has identified mechanisms that extend beyond the specific diagnostic boundaries of the illness:

  • Post-viral autoimmunity: Plasma cell-mediated GPCR autoantibodies (Chapter Immune System Dysfunction)
  • Autonomic-vascular integration: \(\beta\) 2-adrenergic receptor dysfunction linking MCAS, POTS, and vascular dysfunction
  • Mitochondrial pathophysiology: WASF3-mediated ER stress, NAD+ depletion, oxidative stress cascades
  • Neuroinflammation: Microglial activation, glymphatic clearance failure
  • Exercise intolerance mechanisms: Two-day CPET findings revealing autonomic-metabolic integration failure These mechanisms are not exclusive to ME/CFS. They represent fundamental pathophysiological processes that manifest across multiple conditions.

2 Certainty Levels for Cross-Condition Application

When applying ME/CFS findings to other conditions, we use a three-tier certainty framework:

  • High Certainty: Mechanism documented in both ME/CFS and target condition; treatment tested in both
  • Medium Certainty: Mechanism documented in ME/CFS; strong biological plausibility for target condition; shared clinical features
  • Low Certainty: Mechanism documented in ME/CFS; theoretical applicability to target condition; requires validation Important: All translational recommendations require validation through condition-specific research. These findings represent research opportunities, not established clinical guidelines for non-ME/CFS conditions.